Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
Conditions
Interventions
Intervention1: Liv Shuddhi Tablets: Test Product: Liv Shuddhi Tablets
Dose: 1 tablet TID
Route of Administration: Oral
Duration: 30 Days
Control Intervention1: Not Applicable: Not Applicable
Sponsors
Jeena Sikho Lifecare Limited
Eligibility
Inclusion criteria
Inclusion criteria: Subject from 18 to 65 years of age. Subject having SGPT range above 56 unit per litre Subjects that are able to give written informed consent in a manner approved by the institutional ethics committee and comply with the requirements of the study. Subject willing to avoid participation in any other interventional clinical trial for the duration of the study.
Exclusion criteria
Exclusion criteria: Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including oral or parenteral corticosteroids. Subject having SGPT above 300unit/litre should exclude from the study. Subjects that have participated in any other interventional clinical trial in the previous 90 days. Subjects with known sensitivity to any of the constituents of the investigational product. Any clinically significant systemic or cutaneous disease, which may interfere with study treatment or procedures. Chronic illness which may influence the outcome of the study. Pregnant/nursing mothers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Change in LFT profile 2. Change in KFT(Kidney Function Test) profile 3. Change in Lipid Profile 4. Change CBC parameters 5. Change in Subject Global Assessment Timepoint: At T+1day, T+30days | — |
Secondary
| Measure | Time frame |
|---|---|
| Not ApplicableTimepoint: Not Applicable | — |
Countries
India
Contacts
Public ContactPuneet Mittal
CCFT Laboratories
Outcome results
None listed